However, the percentages of colocalized CDH2 and Cx43 in hematological malignancies were significantly (P < 0.05) less than the number of slides with positive colocalized CDH2/Cx43 from BC patients (Fig 3B). This evidence concerns the gene GJA1 and breast cancer.